Skip to main content
. 2021 Feb 17;325(14):1469–1470. doi: 10.1001/jama.2021.1545

Table. Clinical Characteristics of 675 Study Patients.

Characteristics No. (%)a
Age, median (IQR), y 63 (53-72)
Age group, y
18-44 92 (14)
45-64 267 (40)
65-74 199 (29)
75-84 102 (15)
≥85 15 (2)
Sex
Female 270 (40)
Male 405 (60)
Race/ethnicityb
Non-Hispanic White 259 (38)
Hispanic 286 (42)
Native American 68 (10)
Black 28 (4)
Body mass index, median (IQR)c 33 (29-39)
Medications
Dexamethasone 255 (36)
Remdesivir 326 (48)
Anticoagulants 607 (90)
Norepinephrine 33 (5)
Comorbidities
Diabetes 413 (61)
Hypertension 500 (74)
Coronary artery disease 134 (20)
Chronic obstructive lung disease 112 (17)
Cancer 67 (10)
Laboratory values, median (IQR)
C-reactive protein, mg/L 168 (96-260)
D-dimer, μg/mL 1.76 (0.93-4.66)
Brain-type natriuretic peptide, pg/mL 461 (180-1328)
Creatinine, mg/dLd 0.9 (0.65-1.30)
Bilirubin, mg/dLd 0.6 (0.4-0.9)
Ratio of Pao2 to Fio2d 56 (50-68)
Platelets, ×103/μLd 225 (164-299)
Arterial pressure, mean (IQR), mm Hgd 74 (64-84)
Glasgow Coma Scale score, median (IQR)d 15 (13-15)

Abbreviations: IQR, interquartile range; Fio2, fraction of inspired oxygen.

SI conversion factors: To convert bilirubin to μmol/L, multiply by 17.104; creatinine to μmol/L, multiply by 88.4; D-dimer to nmol/L, multiply by 5.476.

a

Unless otherwise indicated.

b

Self-reported at hospital admission and was assessed to aid consideration of the generalizability of the study findings.

c

Calculated as weight in kilograms divided by height in meters squared.

d

Indicates the variables that were incorporated into the Sequential Organ Failure Assessment score.